MetaADEDB 2.0 @ LMMD
Pain management
(UMLS:C0002766)
Definition:
A form of therapy that employs a coordinated and interdisciplinary approach for easing the suffering and improving the quality of life of those experiencing pain.
UMLS ID:
C0002766
MeSH ID:
D059408
Classification 1:
Name:
Therapeutics
MeSH Tree Number(s):
E02.745
Classification 2:
Name:

Notice: Undefined index: N04 in /var/www/metaadedb/ADE.php on line 175
MeSH Tree Number(s):
N04.590.607.500
Synonym(s)
1.
Pain management
2.
Analgesia
3.
Controlling pain
4.
Giving pain relief
5.
Managing Pain
6.
Managing pain
7.
PAIN MANAGEMENT
8.
Pain Control
9.
Pain Management
10.
Pain Therapy
11.
Pain coping assistance individual each 15 minutes
12.
Pain, Pain Management
13.
Pain--Treatment
14.
Relieving pain
15.
actions regarding pain
16.
analgesia
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1rofecoxibFAERS: 10US FAERS
2AlendronateFAERS: 4US FAERS
3EpoprostenolFAERS: 4US FAERS
4NuvaRingFAERS: 3US FAERS
5TeriparatideFAERS: 3US FAERS
6CapecitabineFAERS: 2US FAERS
7MDV 3100FAERS: 2US FAERS
8TopiramateFAERS: 2US FAERS
9AnastrozoleFAERS: 1US FAERS
10DeferasiroxFAERS: 1US FAERS
11LenalidomideFAERS: 1US FAERS
12LoperamideFAERS: 1US FAERS
13OmeprazoleFAERS: 1US FAERS
14apixabanFAERS: 1US FAERS
15apremilastFAERS: 1US FAERS
16lenvatinibFAERS: 1US FAERS
17pazopanibFAERS: 1US FAERS
18treprostinilFAERS: 1US FAERS
19BenzodiazepinesOFFSIDES
20DothiepinOFFSIDES
21LeflunomideOFFSIDES
22MelphalanOFFSIDES
23RivastigmineOFFSIDES
24SorafenibOFFSIDES
25acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamideCanada Vigilance: 1Canada Vigilance
26carbidopa, levodopa drug combinationOFFSIDES
27entacaponeOFFSIDES
28regorafenibCanada Vigilance: 1Canada Vigilance
Similar ADE(s)
NameSemantic Similarity
1Mechanical ventilation24.3%
2Plasmapheresis21.8%
3Manual Lymphatic Drainage21.1%
4Bed rest20.5%
5Inhalation Therapy20.5%
6Phototherapy20.5%
7Respiratory Therapy20.5%
8Salvage Therapy20.5%
9Renal Replacement Therapy20.5%
10Apitherapy20.5%
11Chemotherapy20.5%
12Cryotherapy20.5%
13Enteral Nutrition19.6%
14Parenteral Nutrition19.6%
15Massage18%
16Peritoneal Dialysis17.5%
17Antibiotic Prophylaxis17.5%
18Intubation15.7%
19Continuous Positive Airway Pressure15.5%
20Lithotripsy15.1%
21Laser Therapy15.1%
22Brachytherapy14.6%
23Chelation Therapy14.6%
24Diathermy14.6%
25Premedication14.6%
26Sclerotherapy14.6%
27Tocolysis14.6%
28Male Contraception14.6%
29Pleurodesis14.6%
30Phytotherapy14.6%
31Nutritional Support14.6%
32Hormone replacement therapy14.6%
33Transcranial magnetic stimulation14.6%
34Patient Isolation14.6%
35Leukapheresis14.5%
36Plasma Exchange11.9%
37Injection11.9%
38Neurological Rehabilitation11.7%
39Deep Brain Stimulation11.3%
40Extracorporeal Membrane Oxygenation10.9%
41Radiofrequency Ablation10.9%
42Cementoplasty10.9%
43Dermabrasion10.7%
44Electrocoagulation10.7%
45Medication Error10.7%
46Palliative Care10.7%
47Face Lift10.7%
48intensive care10.7%
49Inappropriate Prescribing10.6%
50Platelet Transfusion10.6%
51Paracentesis10.6%
52Ovulation Induction8.8%
53Relaxation Therapy8.8%
54Vertebroplasty8.8%
55Hospice Care8.7%
56Barium Enema8.7%
57Preoperative Care8.6%
58rhinoplasty8.6%
59Drug Overdose8%
60Photopheresis8%
61Immunosuppression8%
62Ketogenic Diet7.7%
63Immunoglobulin Therapy7.4%
64Angioplasty7%
65Postoperative Care7%
66Bottle feeding6.9%
67venipuncture6.9%
68Euthanasia6.8%
69Gastroplasty6.4%
70Keratoplasty6.2%
71Superovulation6.1%
72Atherectomy5.7%
73Gastric Bypass5.2%
74treatment failure1.7%
75Glasgow coma scale1.4%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.